300 (PB-116) Poster - Real-world analysis of genomic signature indications and impact on adjuvant chemoendocrine therapy (CET) decisions: experience from the French LISE cohort (n = 301).

Authors :: Cutuli, B.
Charles, C.
Bancheri, F.
Caron, Y.
Coeffic, D.
Colin, P.
Dorangeon, P.H.
Ferrand, S.
Gavillon, N.
Hemery, C.G.
Jovenin, N.
Krebs, L.
Majidi, A.R.
Mallet, F.
Mina, W.
Prulhiere-Corviole, K.
Terrosi, P.
Theillier, A.
Veron-Leclercq, I.
Yazbek, G.
Source :: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.
Publication Year :: 2024

Subjects :: *GENOMICS
*CONFERENCES & conventions
*ADJUVANT chemotherapy
*HORMONE therapy
*TUMORS
TUMOR genetics

Full Text Access

Tools